Fig. 3From: Y90 Radioembolization in chemo-refractory metastastic, liver dominant colorectal cancer patients: outcome assessment applying a predictive scoring systemKaplan-Meier estimation for overall survival (n = 87) after first radioembolization, groups of patients with survival benefit (score of 0/1) vs. no survival benefit (score of 2/3). Since all patients had died by the time of analysis, no censored patients occur in the graph. Median OS was 10.4 months (score 0 or 1) vs. 5.1 months (score 2 or 3), p < 0.001Back to article page